A new study published in The Lancet Regional Health – Americas reveals that suicide among adolescents and young adults in the Americas has risen sharply over the past two decades, making it the third leading cause of death for individuals aged 10 to 24. In 2021 alone, 18,157 young people died by suicide in the region, with three-quarters of cases occurring among males. However, the increase has been faster among females, and the most alarming rise has been in the youngest group, ages 10 to 14.
The Pan American Health Organization (PAHO) emphasized that suicide rates among young people have grown by 38% since 2000, compared to a 17% increase in the general population. Factors contributing to this trend include depression and anxiety appearing earlier in life, substance use, cyberbullying, social pressures, and access to lethal means. Many of these drivers are preventable or treatable if identified early, underscoring the need for stronger detection and intervention in schools and communities.
Data from the World Health Organization covering 35 countries between 2000 and 2021 shows that suicide mortality among youth rose from 5.7 to 7.84 deaths per 100,000, with particularly high levels in North America and parts of the Southern Cone. Experts stress the importance of school-based mental health promotion, socio-emotional skills programs, early identification of at-risk individuals, and responsible media reporting.
Since 2000, suicide mortality in the general population of the Americas has increased by more than 17%, making it the only region globally where rates continue to rise. In response, PAHO launched the Regional Suicide Prevention Initiative in 2025 to help countries implement evidence-based interventions, expand mental health services, and reduce stigma.
PAHO Director Dr. Jarbas Barbosa highlighted that suicide is preventable and called for political commitment, investment, and cross-sector collaboration to save lives. The initiative aims to strengthen national plans and ensure timely support for children, adolescents, and young adults, who remain at the highest risk.
